Provided by Tiger Fintech (Singapore) Pte. Ltd.

Eli Lilly

821.86
-2.2000-0.27%
Post-market: 822.650.7900+0.10%17:16 EDT
Volume:3.01M
Turnover:2.48B
Market Cap:779.26B
PE:70.18
High:834.65
Open:814.95
Low:813.26
Close:824.06
Loading ...

BRIEF-Eli Lilly Reports Q4 Worldwide Mounjaro Revenue Increased 60% To $3.53 Billion

Reuters
·
06 Feb

Eli Lilly Adjusted Profit Tops Estimates as Weight-Loss Drug Sales Fall Short

Investopedia
·
06 Feb

Eli Lilly (NYSE:LLY) Reports Q4 In Line With Expectations, Full-Year Outlook Slightly Exceeds Expectations

StockStory
·
06 Feb

Eli Lilly Q4 Non-GAAP Earnings, Revenue Increase; 2025 Outlook Issued

MT Newswires Live
·
06 Feb

Lilly issues 2025 profit view as it steers for revenue boost

Dow Jones
·
06 Feb

BUZZ-Eli Lilly rises after higher-than-expected 2025 profit forecast

Reuters
·
06 Feb

Lilly: Q4 Earnings Snapshot

Associated Press Finance
·
06 Feb

Lilly reassures investors that weight-loss drug demand is strong, shares rise

Reuters
·
06 Feb

Eli Lilly Forecasts 2025 Profit Largely Above Estimates on Launch of Weight-Loss Drug in New Markets

Reuters
·
06 Feb

Eli Lilly Shares up 1.5% Premarket After Co Forecasts 2025 Profit Above Estimates

THOMSON REUTERS
·
06 Feb

Eli Lilly Expects 2025 Adjusted EPS Of $$22.50-$24.00. Versus Consensus Of $12.64

Benzinga
·
06 Feb

Eli Lilly: Anticipate +60% Saleable Incretin Doses in 1H 2025 VS. 1H 2024

THOMSON REUTERS
·
06 Feb

Eli Lilly forecasts 2025 profit largely above estimates on launch of weight-loss drug in new markets

Reuters
·
06 Feb

Eli Lilly Q4 2024 Adj EPS $5.32 Beats $4.94 Estimate, Sales $13.53B Miss $13.57B Estimate

Benzinga
·
06 Feb

Eli Lilly: for Q4, Worldwide Mounjaro Revenue Increased 60% to $3.53 Bln

THOMSON REUTERS
·
06 Feb

Lilly Outlook FY EPS USD 22.05-23.55

THOMSON REUTERS
·
06 Feb